Literature DB >> 12648718

[Brachytherapy in head and neck cancers].

J J Mazeron1, G Noël, J M Simon, S Racadot, E Jauffret.   

Abstract

Experience accumulated over several decades with radiation of Head and Neck tumours by irradiation has demonstrated the need for a high tumour dose to achieve local control. With external beam irradiation alone, it is difficult to spare adjacent normal tissues, resulting in undesirable late effects on the salivary glands, mandible, and muscles of mastication. Interstitial implantation is ideally suited to deliver a high dose limited to the volume of the primary tumor, thus minimizing sequels. A large experience has been accumulated with low dose rate (LDR) brachytherapy in treatment of carcinoma of oral cavity, oropharynx, and nasopharynx. Recent analysis of large clinical series provided data indicating that modalities of low dose rate brachytherapy should be optimized in treating these tumors for increasing therapeutic ratio. Low dose rate brachytherapy is now challenged by high dose rate (HDR) brachytherapy and pulsed dose rate (PDR) brachytherapy. Preliminary results obtained with these two last modalities are discussed regarding to those of low dose rate brachytherapy.

Entities:  

Mesh:

Year:  2003        PMID: 12648718     DOI: 10.1016/s1278-3218(02)00286-x

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  7 in total

1.  Combination of cryosurgery and Iodine-125 seeds brachytherapy for lung cancer.

Authors:  Lizhi Niu; Liang Zhou; Kecheng Xu; Feng Mu
Journal:  J Thorac Dis       Date:  2012-10       Impact factor: 2.895

2.  Biological effects of low-dose-rate irradiation of pancreatic carcinoma cells in vitro using 125I seeds.

Authors:  Zhong-Min Wang; Jian Lu; Li-Yun Zhang; Xiao-Zhu Lin; Ke-Min Chen; Zhi-Jin Chen; Fen-Ju Liu; Fu-Hua Yan; Gao-Jun Teng; Ai-Wu Mao
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

Review 3.  [Brachytherapy in combination with function-preserving surgery. An interdisciplinary challenge].

Authors:  J E Meyer; C Brocks; E Gehrking; G Kovács; B Neppert; J Gliemroth; B Wollenberg
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

4.  Salvage for cervical recurrences of head and neck cancer with dissection and interstitial high dose rate brachytherapy.

Authors:  Antonio Cassio Assis Pellizzon; João Victor Salvajoli; Luiz Paulo Kowalski; Andre Lopes Carvalho
Journal:  Radiat Oncol       Date:  2006-08-08       Impact factor: 3.481

5.  Role of high dose rate interstitial brachytherapy in early and locally advanced squamous cell carcinoma of buccal mucosa.

Authors:  Parthasarathy Vedasoundaram; Aravind Kumar Prasanna; Reddy Ks; Gangothri Selvarajan; Mourougan Sinnatamby; Seenisamy Ramapandian; Saravanan Kandasamy
Journal:  Springerplus       Date:  2014-10-09

6.  The efficacy and safety of 125I brachytherapy combined with pre-operative transarterial chemoembolization in patients with locally advanced head and neck cancer.

Authors:  Menglong Zhang; Jian Zhang; Bijuan Hu; Liyin Huang; Shanjun Song; Haitao Zhu; Chao Chen; Cunkun Chu
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

7.  Safety and efficacy of apatinib combined with iodine-125 in chemotherapy-refractory advanced lung cancer: A case report.

Authors:  Yunchao Zhang; Shiqiang Yin; Yingjie Jia; Lei Qin
Journal:  Medicine (Baltimore)       Date:  2020-08-14       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.